| Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation |
Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration |
Active, not recruiting |
| Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study |
Lisinopril, Questionnaire Administration, Biospecimen Collection, Liver Ultrasonographic Elastography, Magnetic Resonance Elastography, Magnetic Resonance Imaging, Proton Density Fat Fraction |
Recruiting |
| Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients |
Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Biospecimen Collection, Endoscopic Biopsy, MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP, Questionnaire Administration |
Recruiting |
| Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis |
Atorvastatin Calcium, Biopsy of Colon, Biospecimen Collection, Placebo Administration, Questionnaire Administration |
Recruiting |
| Testing Obeticholic Acid for Familial Adenomatous Polyposis |
Biopsy, Obeticholic Acid, Placebo Administration, Biospecimen Collection, Gastrointestinal Endoscopy, Questionnaire Administration |
Recruiting |
| Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome |
Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5, Biopsy, Biospecimen Collection, Colonoscopy, Nogapendekin Alfa, Placebo Administration, Questionnaire Administration |
Recruiting |
| Obeticholic Acid for Prevention in Barrett's Esophagus |
Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy, Liver Ultrasonographic Elastography, Obeticholic Acid, Placebo Administration, Questionnaire Administration |
Recruiting |
| Chemoprevention of Gastric Carcinogenesis |
Eflornithine, Eflornithine placebo |
Active, not recruiting |